TP53 mutations are highly prevalent in a wide variety of human cancers and have often been found to lead to a double-edged effect: loss of crucial tumor-suppressive functions and gain of traits that fuel cancer growth, for which reactivation of the mutant p53 is required for recovery to normal functionality of the p53 protein. This evidence concerns the gene TP53 and neoplasm.